Feb 10 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O:
ASL STRATEGIC VALUE FUND: AVADEL PHARMACEUTICALS SHOULD IMMEDIATELY RETAIN AN INVESTMENT BANK TO EXPLORE ALL POSSIBLE ALTERNATIVES, INCLUDING SALE
ASL STRATEGIC VALUE FUND: AVADEL SHOULD ISSUE TO SHAREHOLDERS CONTINGENT VALUE RIGHT FOR RECOVERY FROM LITIGATION AGAINST JAZZ PHARMACEUTICALS
Source text: ID:nBw5bbj02a
Further company coverage: AVDL.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.